Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BTAI
BTAI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BTAI News
India's AI Strategy Faces Significant Challenges Amid U.S. Restrictions
2d ago
CNBC
India's Film Industry Accelerates Generative AI Adoption
Jun 11 2026
CNBC
India's Stock Market Faces Pressure from AI Competition
Jun 04 2026
CNBC
BioXcel Presents Positive Data for BXCL501 in Agitation Treatment
May 28 2026
Newsfilter
Middle East Conflict Boosts India's Domestic Tourism Boom
May 28 2026
CNBC
BioXcel Therapeutics Q1 Earnings Report Analysis
May 15 2026
seekingalpha
BioXcel to Host Virtual Event on April 23 to Discuss Launch Strategy for IGALMI
Apr 17 2026
Newsfilter
Investigation into BioXcel Therapeutics' Corporate Governance Breaches
Apr 10 2026
PRnewswire
BioXcel Initiates Phase 2a Study for Acute Stress Reactions
Apr 08 2026
NASDAQ.COM
BioXcel Initiates Clinical Trial for ASR Treatment
Apr 08 2026
Newsfilter
BioXcel Submits sNDA for IGALMI® in At-Home Treatment
Mar 27 2026
Newsfilter
BioXcel Therapeutics Q4 Earnings Beat Expectations
Mar 27 2026
seekingalpha
BioXcel Therapeutics Enters Securities Purchase Agreement for $8 Million Offering
Mar 10 2026
Newsfilter
BioXcel Therapeutics Shares Decline Despite Positive Drug Development News
Mar 06 2026
Benzinga
BIOXCEL THERAPEUTICS STOCK INCREASES 2.7% FOLLOWING POSITIVE RESULTS FROM MID-STAGE TRIAL OF EXPERIMENTAL OPIOID WITHDRAWAL TREATMENT
Mar 05 2026
moomoo
BioXcel Therapeutics Reports Positive Phase 2 Results for Opioid Withdrawal Treatment
Mar 05 2026
Benzinga
Show More News
